The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher

doi:10.1136/bmj.n71

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan, Roger Chou, Julie Glanville, Jeremy M Grimshaw, Asbjørn Hróbjartsson, Manoj M Lalu, Tianjing Li, Elizabeth W Loder, Evan Mayo-Wilson, Steve McDonald, Luke A McGuinnessLesley A Stewart, James Thomas, Andrea C Tricco, Vivian A Welch, Penny Whiting, David Moher

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Review article › Research › peer-review

39480 Citations (Scopus)

920 Downloads (Pure)

Abstract

Summary points
- To ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they found
- The PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studies
- The PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviews
- We anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders

Original language	English
Article number	n71
Journal	BMJ (Clinical research ed.)
Volume	372
DOIs	https://doi.org/10.1136/bmj.n71
Publication status	Published - 29 Mar 2021

Access to Document

10.1136/bmj.n71Licence: CC BY

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsFinal published version, 316 KBLicence: CC BY

Cite this

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372, Article n71. https://doi.org/10.1136/bmj.n71

@article{ccbeeada3050429ebbf3df68741c9710,

title = "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",

abstract = "Summary points- To ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they found- The PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studies- The PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviews- We anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders",

author = "Page, {Matthew J} and McKenzie, {Joanne E} and Bossuyt, {Patrick M} and Isabelle Boutron and Hoffmann, {Tammy C} and Mulrow, {Cynthia D} and Larissa Shamseer and Tetzlaff, {Jennifer M} and Akl, {Elie A} and Brennan, {Sue E} and Roger Chou and Julie Glanville and Grimshaw, {Jeremy M} and Asbj{\o}rn Hr{\'o}bjartsson and Lalu, {Manoj M} and Tianjing Li and Loder, {Elizabeth W} and Evan Mayo-Wilson and Steve McDonald and McGuinness, {Luke A} and Stewart, {Lesley A} and James Thomas and Tricco, {Andrea C} and Welch, {Vivian A} and Penny Whiting and David Moher",

year = "2021",

month = mar,

day = "29",

doi = "10.1136/bmj.n71",

language = "English",

volume = "372",

journal = "BMJ (Clinical research ed.)",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

}

Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, Shamseer, L, Tetzlaff, JM, Akl, EA, Brennan, SE, Chou, R, Glanville, J, Grimshaw, JM, Hróbjartsson, A, Lalu, MM, Li, T, Loder, EW, Mayo-Wilson, E, McDonald, S, McGuinness, LA, Stewart, LA, Thomas, J, Tricco, AC, Welch, VA, Whiting, P & Moher, D 2021, 'The PRISMA 2020 statement: an updated guideline for reporting systematic reviews', BMJ (Clinical research ed.), vol. 372, n71. https://doi.org/10.1136/bmj.n71

TY - JOUR

T1 - The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

AU - Page, Matthew J

AU - McKenzie, Joanne E

AU - Bossuyt, Patrick M

AU - Boutron, Isabelle

AU - Hoffmann, Tammy C

AU - Mulrow, Cynthia D

AU - Shamseer, Larissa

AU - Tetzlaff, Jennifer M

AU - Akl, Elie A

AU - Brennan, Sue E

AU - Chou, Roger

AU - Glanville, Julie

AU - Grimshaw, Jeremy M

AU - Hróbjartsson, Asbjørn

AU - Lalu, Manoj M

AU - Li, Tianjing

AU - Loder, Elizabeth W

AU - Mayo-Wilson, Evan

AU - McDonald, Steve

AU - McGuinness, Luke A

AU - Stewart, Lesley A

AU - Thomas, James

AU - Tricco, Andrea C

AU - Welch, Vivian A

AU - Whiting, Penny

AU - Moher, David

PY - 2021/3/29

Y1 - 2021/3/29

N2 - Summary points- To ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they found- The PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studies- The PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviews- We anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders

AB - Summary points- To ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they found- The PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studies- The PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviews- We anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders

UR - http://www.scopus.com/inward/record.url?scp=85103451714&partnerID=8YFLogxK

U2 - 10.1136/bmj.n71

DO - 10.1136/bmj.n71

M3 - Review article

C2 - 33782057

SN - 0959-535X

VL - 372

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

M1 - n71

ER -

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Abstract

Access to Document

Other files and links

Fingerprint

Cite this